Приложение Руководство для медперсонала по безопасному обращению. Руководство для медицинского персонала по безопасному обращению с противоопухолевыми препаратами
 Скачать 346.63 Kb.
|
|
Руководство для медицинского персонала – 56 – Список литературы 1). Fransman,.W.,.Roeleveld,.N.,.Peelen,.S.,.de.Kort,.W.,.Kromhout,.H.,.&.Heederik,.D..2007..Nurses.with.dermal. exposure.to.antineoplastic.drugs:.reproductive.outcomes..Epidemiology,.18(1):.112119 2). IARC..Agents.Classified.by.the.IARC.Monographs,.Volumes.1–102 3). Kromhout,. H.,. Hoek,. F.,. Uitterhoeve,. R.,. Huijbers,. R.,. Overmars,. R.. F.,. Anzion,. R.,. &. Vermeulen,. R.. 2000.. Postulating. a. dermal. pathway. for. exposure. to. antineoplastic. drugs. among. hospital. workers.. Applying. a. conceptual.model.to.the.results.of.three.workplace.surveys..Ann.Occup.Hyg,.44(7):.551560 4). Krstev,. S.,. Perunicic,. B.,. &. Vidakovic,. A.. 2003.. Work. practice. and. some. adverse. health. effects. in. nurses. handling.antineoplastic.drugs..Med.Lav,.94(5):.432439 5). McAbee,.R..R.,.Gallucci,.B..J.,.&.Checkoway,.H..1993..Adverse.reproductive.outcomes.and.occupational. exposures.among.nurses:.an.investigation.of.multiple.hazardous.exposures..AAOHN.J,.41(3):.110119. 6). Meyer,.H..W.,.&.Skov,.P..S..2010..Occupational.rhinosinusitis.due.to.etoposide,.an.antineoplastic.agent..Scand. J.Work.Environ.Health,.36(3):.266267 7). Mosteller,.R..D..1987..Simplified.calculation.of.bodysurface.area..N.Engl.J.Med,.317(17):.1098 8). QueruauLamerie,.T.,.Carrez,.L.,.Decaudin,.B.,.Bouchoud,.L.,.Goossens,.J..F.,.Barthelemy,.C.,.Bonnabry,. P.,.&.Odou,.P..2011..Multipletest.assessment.of.devices.to.protect.healthcare.workers.when.administering. cytotoxic.drugs.to.patients..J.Oncol.Pharm.Pract 9). Sessink,.P..J.,.Connor,.T..H.,.Jorgenson,.J..A.,.&.Tyler,.T..G..2011..Reduction.in.surface.contamination.with. antineoplastic.drugs.in.22.hospital.pharmacies.in.the.US.following.implementation.of.a.closedsystem.drug. transfer.device..J.Oncol.Pharm.Pract,.17(1):.3948 10). Walusiak,.J.,.Wittczak,.T.,.Ruta,.U.,.&.Palczynski,.C..2002..Occupational.asthma.due.to.mitoxantrone..Allergy,. 57(5):.461 11). Bos.RP.et.al.Mutagenicity.of.urine.from.nurses.handling.cytostatics.drugs,.influence.of.smoking...Int..Arch.. Occup..nviron.Health.50.(1982):.359369 12). Bos.RP.Sessink.PJ..Biomonitoring.of.occupational.exposures.to.cytostatic.anticancer.drugs..Rev..Inviron.. Health.12.(1997):.4358 13). Nava. C.. Contributo. alio. studio. della. patologia. comparsa. in. lavoratoria. adetti. alia. produzione. et. alia. somministrazione.di.citostatici..Boll..Chim..Farm..123.(1984):.547.551 14). Gabriele.P.et.al..Undifferentiated.nasopharyngealtype.carcinoma.in.a.nurse.handling.cytostatic.agents..Eur.. J..Cancer.В.Oral.Oncol..29B.(1993):.153 15). Levin.LI.et.al..Bladder.cancer.in.a.39yearold.femal.pharmacist..J..Natl..Cancer.Inst..85(1993):.10891091 16). Hemminki.К.et.al..Spontaneous.abortions.and.malformations.in.the.offspring.of.nur.ses.exposed.to.anaesthetic. gases,.cytostatic.drugs,.and.other.potential.hazards.in.hospitals,.based.on.registered.information.of.outcome.. J..Epidemiol..Community.Health.39.(1985):.141147 17). Falck.К.et.al..Mutagenicity.in.urine.of.nurses.handling.cytostatic.drugs..Lancet.1.(1979):.12501251 18). Benhamou.S.et.al..Mutagenicity.in.urine.from.nurses.handling.cytostatic.agents..Eur..J.Clin..Oncol..22(1986):. 1489.1493 19). Cavallo.D.et.al..Evaluation.of.genotoxic.effects.induced.by.the.exposure.to.antineoplastic.drugs.in.lymphocytes. and.exfoliated.buccal.cells.of.oncology.nurses.and.pharmacy.employees..Mutat..Res..587.(2005):.4551 20). Ensslin. AS. et. al.. Urinary. platinum. in. hospital. personnel. occupational^. exposed. to. platinumcontaining. antineoplastic.drugs..Int..Arch..Occup..Environ..Health.65.(1994):.339342 21). Nygren.O,.Lundgren.C..Determination.of.platinum.in.workroom.air.and.in.blood.and.urine.from.nursing.staff. attending.patients.receiving.cisplatin.chemotherapy..Int..Arch..Occup..Environ..Health.70.(1997):.209214 Руководство для медицинского персонала – 57 – 22). Burgaz.S.et.al..Assessment.of.genotoxic.damage.in.nurses.occupational^.exposed.to.antineoplastics.by.the. analysis.of.chromosomal.aberrations..Hum..Exp..Toxicol..21.(2002):.129135 23). FUChs.J.et.al..DNA.damage.in.nurses.handling.antineoplastic.agents..Mutat..Res..342.(1995):.1723 24). CrausteManciet.S.et.al..Environmental.contamination.with.cytotoxic.drugs.in.health.care.using.positive.air. pressure.isolators..Ann..Occup..Hyg..49.(2005):.619628 25). Delporte. JP. et. al.. Chemical. contamination. of. the. primary. packaging. of. 5fluorouracil. rtu. solutions. commercially.available.on.the.Belgian.market..Eur..Hosp..Pharm..5.(1999):.119121 26). Kiffmeyer. TK. et. al.. External. contamination. of. drug. packaging.. Suggestions. for. a. cleaning. procedure.. Krankenhauspharmazie.22.(2001):.207212.(in.German) 27). Favier. В. et. al.. Contamination. of. syringe. plungers. during. the. sampling. of. cyclophos.phamide. solutions.. J.. Oncol..Pharm..Pract..11.(2005):.15 28). Hansel.S.et.al..Chemical.degradation.of.wastes.of.antineoplastic.agents:.cyclophos.phamide,.ifosfamide.and. melphalan..Int..Arch..Occup..Environ..Health.69.(1997):.109114 29). Harrison.BR..Kloos.MD..Penetration.and.splash.protection.of.six.disposable.gown.materials.against.fifteen. antineoplastic.drugs..J..Oncol..Pharm..Practice.5.(1999):.6166 30). Hedmer.M.et.al..Development.and.validation.of.methods.for.environmental.moni.toring.of.cyclophosphamide. in.workplaces..J..Environ..Monit..6.(2004):.979984 31). Hedmer. M. et. al.. Surface. contamination. of. cyclophosphamide. packaging. and. surface. contamination. with. antineoplastic.drugs.in.a.hospital.pharmacy.in.Sweden..Ann..Occup..Hyg..49.(2005):.629637 32). Hemminki.К.et.al..Spontaneous.abortions.and.malformations.in.the.offspring.of.nur.ses.exposed.to.anaesthetic. gases,.cytostatic.drugs,.and.other.potential.hazards.in.hospitals,.based.on.registered.information.of.outcome.. J..Epidemiol..Community.Health.39.(1985):.141147 33). Hepp. R,. Gentschew. G.. External. contamination. of. commercially. available. cytotoxic. drug. vials.. Krankenhauspharmazie.1.(1998):.2227.(in.German) 34). Herrington.JD,.Figueroa.JA..Severe.necrosis.due.to.paclitaxel.extravasation..Pharmacotherapy.17.(1997):. 163165 35). Hessel.H.et.al..The.genotoxic.risk.of.hospital,.pharmacy.and.medical.personnel.occupational^.exposed.to. cytostatic.drugs..evaluation.by.the.micronucleus.assay.Mutat..Res..497.(2001):.101109 36). Jakab.MG.et.al..Followup.genotoxicological.monitoring.of.nurses.handling.antineoplastic.drugs..J.Toxicol.. Environ..Health.A.62.(2001):.170177 37). Jordan.К.et.al..Extravasation.of.chemotherapeutic.agents:.prevention.and.therapy..Dtsch..Med..Wochenschr.. 130.(2005):.3337.(in.German) 38). Jung.D.et.al..Preparation.of.antineoplastic.drug.solutions.in.laminar.flow.cabinets..effects.on.pregnancy.and. offspring.of.pharmacy.personnel..Krankenhauspharmazie.22.(2001):.310.(in.German) 39). Larson.RR.et.al..Development.of.an.HPLC.method.for.simultaneous.analysis.of.five.antineoplastic.agents.. Appl..Occup..Environ..Hyg..18.(2003a):.109119 40). Larson. RR. et. al.. A. new. monitoring. method. using. solid. sorbent. media. for. evaluation. of. airborne. cyclophosphamide.and.other.antineoplastic.agents..Appl..Occup..Environ..Hyg..18.(2003b):.120131 41). Laurenzi.L.et.al..Cutaneous.bacterial.colonization,.modalities.of.chemotherapeutic.infusion,.and.catheterrelated. bloodstream.infection.in.totally.implanted.venous.access.devices..Support.Care.Cancer.12.(2004):.805809 42). Medicines.and.Healthcare.products.regulatory.Agency..Rules.and.Guidance.fa.Pharmaceutical.Manufacterers. and.Distributors.202..London..The.Stationery.Office.(2002).(Rev..to.Annex.1.in.preperation).September.2003 43). Lawrence.HJ.et.al..Topical.dimethylsulfoxide.may.prevent.tissue.damage.from.anthracycline.extravasation.. Cancer.Chemother..Pharmacol..23.(1989):.316318 Руководство для медицинского персонала – 58 – 44). Lee. AYY. et. al.. Incidence,. risk. factors,. and. outcomes. of. catheterrelated. thrombosis. in. adult. patients. with. cancer..J..Clin..Oncol..24.(2006):.14041408 45). Levin.LI.et.al..Bladder.cancer.in.a.39yearold.femal.pharmacist..J..Natl..Cancer.Inst..85(1993):.10891091 46). Levin.M.et.al..Mitoxantrone.extravasation.and.tissue.necrosis..Am.J..Health..Syst..Pharm..53(1996):.1192,1194 47). Loth.TS..Eversmann.WW.Jr..Treatment.methods.for.extravasation.of.chemothera.peutic.agents:.a.comparative. study..J..Hand..Surg..[AM].11.(1986):.388396 48). Mader. RM. et. al.. Exposure. of. oncologic. nurses. to. methotrexate. in. the. treatment. ol. osteosarcoma.. Arch.. Environ..Health.51.(1996):.310314 49). Opiolka.S.et.al..Traces.of.higheffective.pharmaceuticals.in.indoor.air.of.preparation.rooms:.theory..detection. .results..Krankenhauspharmazie.22.(2001):.317324.(in.German) 50). OSHA,.Controlling.occupational.exposure.to.hazardous.drugs..In:.OSHA.Technical.manual.(OSHA.instructions. CPL. 220B. CH4).. Washington.. DC.. Directorate. of. Tech.nical. Support,. Occupational. Safety. and. Health. Administration.(1995):.Chapter.21 51). OSHA..Technical.Manual..TED.10.15A.(1999):.Section.VI,.Chapter.2 52). Ozdemir. FA. et. al.. Spectrophotometric. investigation. of. the. chemical. compatibility. of. the. anticancer. drugs. irinotecanHCI.and.epirubicinHCI.in.the.same.infusion.solution..Cancer.Chemother..Pharmacol..56.(2005):. 52953 53). Paul.H.et.al..Environmental.monitoring.for.contamination.with.antineoplastic.agents..Krankenhauspharmazie. 4.(1998):.181186.(in.German) 54). Pethran.A.et.al..Wipe.samples.of.workplaces.with.cytotoxic.drug.exposure..Kranken.hauspharmazie.22.(2001):. 1115.(in.German) 55). Pethran.A.et.al..Uptake.of.antineoplastic.agents.in.pharmacy.and.hospital.personnel..Part.I:.monitoring.of. urinary.concentrations..Int..Arch..Occup..Environ.Health.76.(2003):.510 56). Pilger.A.et.al..Longterm.monitoring.of.sister.chromatid.exchanges.and.micronucleus.frequencies.in.pharmacy. personnel.occupational^.exposed.to.cytostatic.drugs..Int..Arch..Occup..Environ..Health.73.(2000):.442448 57). NF.Izmerov,..GI.Tikhonova,.NV.Lebedeva..Сongenital.malformations.in.children.and.paternal.occupational. exposures..EPICOH.–.2005.Conf..Univers..of.Bergen..Bergen,.Norway.2628.Sept.2005//.Book.of.Abstr.. Bergen,.2005...P.89. 58). G.I.. Tikhonova. Paternal. occupational. exposures. and. birth. defects. in. children.. IСОН. 2006. Book. of. abst.. 28th.Int..Congress.on.Occup..Health..“Renewing.a.century.of.commitment.to.a.health,.safer.and.productive. working.life”.Milan,.Italy,.June.1116,.2006,.р..136 59). Измерова,.Н..И.,.Кузьмина,.Л..П.,.Королева,.Е..П.,.&.Тихонова,.Г..И..2009..Меры.по.профилактике.на рушений.состояния.здоровья.медицинского.персонала.при.работе.с.цитостатиками,.XIII.Российский. онкологический.конгресс..Москва,.Российская.Академия.Государственной.Службы. 60). Тихонова,.Г..И..2004..Влияние.условий.труда.родителей.на.состояние.здоровья.детей.(эпидемиологи ческие.исследования),.Автореф.дисс..на.соиск.уч.ст..докт..биол.наук:.48..Москва. 61). Тихонова.Г.И..Влияние.условий.труда.родителей.на.состояние.здоровья.детей.(эпидемиологические. исследования).Автореф.дисс..на.соиск.уч.ст..докт..биол.наук.–М.2004.:48.с. 62). Тихонова.Г.И..Оценка.риска.развития.редких.форм.патологии.у.детей.как.следствия.профессиональ ной.экспозиции.родителей.//.Бюл..Науч..Совета.Медикоэкологические.проблемы.работающих...М.. .2004...№.1..С.6569; 63). Тихонова.Г.И.,.Рубцова.Н.Б.,.Яковлева.Т.П..Условия.труда.родителей.как.фактор.риска.развития.врожден ных.пороков.у.детей.Ж.Безопасность.жизнедеятельности..2006.№2.С.5257.] Адрес: 119021.Москва,.ул..Тимура.Фрунзе,.16/3,.офис.316318, тел./факс.(499).245.50.78 Email:.info@russco.org. http://www.rosoncoweb.ru/ Тимофеев Илья Валерьевич Исполнительный.директор,.член.правления Тел.:.+7.(926).564.65.81 Email:.director@russco.org Егорова Юлия Олеговна Менеджер.по.развитию Тел.:.+7.(915).120.92.33 Email:.egorova@russco.org 3071(100) .P7 ..10 ’12 |